FFO
SANA icon

Fortitude Family Office’s Sana Biotechnology SANA Stock Holding History

Fortitude Family Office’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.06K Sell
1,049
-188
-15% -$655 ﹤0.01% 1819
2026
Q2 		$4.32K Buy
1,237
+1,088
+730% +$3.5K ﹤0.01% 1149
2026
Q1 		$429 Buy
+149
New +$587 ﹤0.01% 1783

Other funds holding SANA

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Blue Trust Inc
Blue Trust Inc Alpharetta, Georgia $9.51B AUM 13.02% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
TCM
Triumph Capital Management Denver, Colorado $573M AUM 15.32% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Fortitude Family Office's SANA Position: Q3 2026 in Review

Fortitude Family Office reduced its Sana Biotechnology (SANA) stake by 15% in Q3 2026, selling an estimated $655 and leaving 1,049 shares worth $3.06K. The position accounts for ﹤0.01% of the portfolio, ranked #1819.

Fortitude Family Office first reported a position in SANA in Q1 2026 and has held it in 3 quarters since. The position peaked at $4.32K in Q2 2026. 9 funds tracked by Wall St. Rank hold SANA as of Q3 2026.

  • Fortitude Family Office held 1,049 shares of Sana Biotechnology worth $3.06K as of Q3 2026.
  • Fortitude Family Office sold 188 Sana Biotechnology shares in Q3 2026, an estimated $655.
  • Sana Biotechnology made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #1819 holding.
  • Fortitude Family Office first reported a position in Sana Biotechnology in Q1 2026 and has held it in 3 quarters since.
  • Fortitude Family Office's Sana Biotechnology position peaked at $4.32K in Q2 2026.
  • 9 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.